Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07132086) titled 'Prospective Observational Study on the Effectiveness of Daridorexant in Chronic Insomnia in a Real-World Setting' on Aug. 9.
Study Type: Observational
Primary Sponsor: Azienda Ospedaliero, Universitaria Pisana
Condition:
Insomnia Chronic
Intervention:
Drug: Daridorexant 50 mg orally, once daily at bedtime, administered as monotherapy or add-on therapy for chronic insomnia, in a real-world, observational, prospective clinical setting
Recruitment Status: Not recruiting
Date of First Enrollment: October 1, 2023
Target Sample Size: 31
Countries of Recruitment:
Italy
To know more, visit https://clinicaltrials....